Square Pharmaceuticals’ EPS Rises 21% in First Quarter

Date:

Post View:

Square Pharmaceuticals’ EPS Rises 21% in First Quarter

Square Pharmaceuticals PLC, one of the country’s leading listed pharmaceutical companies, has reported a 21.54% year-on-year increase in earnings per share (EPS) for the first quarter ending September 30, 2025.

The company disclosed its unaudited financial statements for the July–September 2025 quarter following approval by its Board of Directors at a meeting held on Wednesday, November 12.

According to company sources, Square Pharmaceuticals’ consolidated EPS stood at Tk 8.35 for the quarter, compared to Tk 6.87 during the same period last year, reflecting solid growth in earnings.

As of September 30, 2025, the company’s net asset value per share (NAVPS) was reported at Tk 167.50, demonstrating continued financial strength and stability.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_img

Popular

More like this
Related

BB seeks explanation from bKash over 7,900 suspicious accounts

Bangladesh Bank has identified 7,900 suspicious accounts of leading...

Islami Bank seeks fivefold increase in authorised capital

Islami Bank Bangladesh PLC has taken an initiative to...

Community Bank Extends BDT 13 Million in CSR Support to Bangladesh Police Institutions

Community Bank Bangladesh PLC has provided Tk 1 crore...

Super Petrochemical refinery under scrutiny over approval, import irregularities

B.Mirror Desk: A fresh initiative has been taken to...